Triamterene And Hydrochlorothiazide
Product Images NDC 70934-159

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 70934-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

70934 159 30 Master Bottle Label Approval Rev B 02 19

Label for Triamterene and Hydrochlorothiazide Tablets, USP 37.5 mg/25 mg, containing 30 tablets per bottle. The label states it is prescription only and includes dosage instructions and storage conditions. The product is labeled by Denton Pharma, Inc. DBA Northwind Pharmaceuticals with NDC 70934-159.*

FDA Label Image

Triamterene Chemical Structure (Triamterene And Hctz Tabs 1)

Chemical structure of Triamterene showing the molecular formula C12H11N7 with labeled amine groups and rings.*

FDA Label Image

Hydrochlorothiazide Chemical Structure (Triamterene And Hctz Tabs 2)

Chemical structure of Hydrochlorothiazide showing the molecular arrangement, including a chlorinated benzene ring fused to a sulfonamide group and a heterocyclic ring. The image includes the molecular formula C7H8ClN3O4S2 and highlights the presence of chlorine and sulfur atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.